Treats major depressive disorder. ANDA 78301, held by Dr. Reddy's Laboratories. Venlafaxine Hydrochloride.
As of Nov 21, 2026, ANDA 78301 (Venlafaxine Hydrochloride), held by Dr. Reddy's Laboratories, was first approved by FDA on Jun 13, 2008, with 10 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Venlafaxine tablets are indicated for the treatment of major depressive disorder. The efficacy of venlafaxine hydrochloride in the treatment of major depressive disorder was established in 6-week controlled trials of adult outpatients whose diagnoses corresponded most closely to the DSM-III or DSM-III-R category of major depression and in a 4-week controlled trial of inpatients meeting diagnostic criteria for major depression with melancholia (see CLINICAL TRIALS ).
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 13, 2008 | Original application | Approved | None posted |
| Venlafaxine HydrochlorideEQ 25MG BASE · tablet;oral | Venlafaxine Hydrochloride | Rx |
| Venlafaxine HydrochlorideEQ 37.5MG BASE · tablet;oral | Venlafaxine Hydrochloride | Rx |
| Venlafaxine HydrochlorideEQ 50MG BASE · tablet;oral | Venlafaxine Hydrochloride | Rx |
| Venlafaxine HydrochlorideEQ 75MG BASE · tablet;oral | Venlafaxine Hydrochloride | Rx |
| Venlafaxine HydrochlorideEQ 100MG BASE · tablet;oral | Venlafaxine Hydrochloride | Rx |
| Aug 18, 2023 | Supplement 10Labeling · Standard review | Approved | None posted |
| Sep 20, 2021 | Supplement 9Labeling · Standard review | Approved | None posted |
| Jan 4, 2017 | Supplement 8Labeling · Standard review | Approved | None posted |
| Jul 17, 2014 | Supplement 7Labeling · Standard review | Approved | None posted |
| Jun 26, 2014 | Supplement 6Labeling · Standard review | Approved | None posted |
| Sep 19, 2012 | Supplement 5Labeling · Standard review | Approved | None posted |
| Feb 26, 2010 | Supplement 4Labeling | Approved | None posted |
| Feb 26, 2010 | Supplement 3Labeling | Approved | None posted |
| Apr 6, 2009 | Supplement 2Labeling | Approved | None posted |
| Mar 6, 2009 | Supplement 1Labeling | Approved | None posted |
| Jun 13, 2008 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters